Trial
NCT02523690
Evaluating Muscle Weakness Improvement With Lorcaserin in ICU
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Muscle Weakness
Intervention
Lorcaserin
Why stopped
Slow recruitment of eligible patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-01-13